Product Information
MEMANTINE HCL 5 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0793 per EA under NDC 62135089560. Its NADAC has been published 114 times since Jul 31, 2024.
FDA first approved this application on Jul 11, 2018.
Strength
5 mg/1
Manufacturer
Chartwell RX LLCNDC
62135089560
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MEMANTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090244FDA Approved
7/11/2018
On Market Since
7/11/2018
Pharmacological Classes
Price Statistics
The NADAC for MEMANTINE HCL 5 MG TABLET has been published 114 times since Jul 31, 2024, and over the history we have for it it has risen 12.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0793 per EA |
|---|---|
| All-time high | $0.0889 (Jul 16, 2025) |
| All-time low | $0.0674 (Nov 20, 2024) |
| 52-week high | $0.0838 |
| 52-week low | $0.0788 |
| Median price | $0.0815 |
| Average price | $0.0810 |
| Largest weekly change | +22.2% (Aug 21, 2024) |
| Weeks tracked | 114 |
| Tracking since | Jul 31, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
memantine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
N-methyl-D-aspartate Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEMANTINE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE HCL 5 MG TABLET, manufactured by Chartwell RX LLC, is $0.0793 per EA (NDC 62135089560), effective Sep 30, 2026.
How has the price of MEMANTINE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MEMANTINE HCL 5 MG TABLET has risen 12.6%. It has been tracked across 114 weekly CMS publications since Jul 31, 2024.
What are the highest and lowest recorded NADAC prices for MEMANTINE HCL 5 MG TABLET?
Since Jul 31, 2024, the NADAC for MEMANTINE HCL 5 MG TABLET has ranged from a low of $0.0674 (Nov 20, 2024) to a high of $0.0889 (Jul 16, 2025), with a median of $0.0815 per EA.
Are there cheaper alternatives to MEMANTINE HCL 5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MEMANTINE HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MEMANTINE HCL 5 MG TABLET?
MEMANTINE HCL 5 MG TABLET (NDC 62135089560) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.